Screening and Early Detection

610 articles

In the News
November 29, 2023 • 1 Min

Let’s Win in a Spectrum News NY1 Report for Pancreatic Cancer Awareness Month

Cindy Gavin and Dr. Allyson Ocean appeared in a Spectrum News NY1 report on a pancreatic cancer patient, for Pancreatic Cancer Awareness Month.

Research
February 28, 2024 • 1 Min

Enhancing Standard Chemotherapy in Metastatic Pancreatic Cancer

Researchers are testing a new kinase inhibitor as a way to make standard chemotherapy more effective against advanced pancreatic cancer.

Survivor Stories
June 3, 2024 • 4 Min

No Time To Lose

Eduardo Servin acted pretty quickly when he began itching all over and noticed that he was jaundiced. He believes this saved his life.

Research
July 2, 2024 • 3 Min

mRNA Vaccine Trial Expands to Numerous Locations

The mRNA vaccine trial spearheaded by Dr. Vinod Balachandran has opened in more locations in the US and around the world.

Research
July 16, 2024 • 4 Min

Positive Results For Borderline Resectable Disease Pilot Study

Dr. Zev Wainberg provides details on a trial of chemotherapy and immunotherapy for patients with borderline resectable pancreatic cancer.

Survivor Stories
July 19, 2024 • 1 Min

Wonder Wyman

As a long-term survivor Shelly Wyman is determined to educate nurses about the latest information for helping pancreatic cancer patients.

Research
July 24, 2024 • 2 Min

Testing a New Chemo and RNA Therapy Combination

Researchers are testing a new drug that binds to messenger RNA in combination with mFOLFIRINOX chemotherapy.

Survivor Stories
August 21, 2024 • 1 Min

You Can Be the Outlier

When long-term survivor Leanne Pierce was diagnosed with stage IV pancreatic cancer, she knew she wanted to be around for her young sons.

Research
September 10, 2024 • 3 Min

A New Combination Targeting the RAS Pathway

Researchers are testing two new drugs that target the RAS pathway, to make standard chemotherapy more effective.

Research
October 17, 2024 • 3 Min

A New Approach to Overcome Drug Resistance

Dr. Despina Siolas is leading one of the sites where a new drug combination to combat the effects of KRAS mutations is under trial.